Physician profile
Jeffrey M Segil
NPI 1932298650
$70,434.22
in general payments reported to CMS, 2019-2025
14 companies · $35K in 2025
The $35K reported for 2025 was more than what 99% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,565 · 2020: $132 · 2021: $115 · 2022: $717 · 2023: $708 · 2024: $32K · 2025: $35K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $52K · Food and Beverage: $4,782 · Consulting Fee: $4,200 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,000 · Travel and Lodging: $2,774.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $52,150.00 |
| Food and Beverage | $4,781.82 |
| Consulting Fee | $4,200.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,000.00 |
| Travel and Lodging | $2,773.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $61,914.85 | 2019-2025 | Da Vinci Surgical System |
| Conmed Corporation | $4,420.16 | 2023-2025 | Airseal, Vcare |
| Boston Scientific Corporation | $2,180.01 | 2019-2025 | Solyx Sis System, Axonics |
| Gynesonics, INC. | $401.32 | 2022-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Abbvie INC. | $396.92 | 2019-2025 | |
| Axonics, INC. | $375.45 | 2021-2024 | Bulkamid, Axonics |
| Sumitomo Pharma America, INC. | $278.48 | 2023-2025 | Myfembree, Gemtesa |
| Medtronic USA, INC. | $148.16 | 2019-2020 | |
| Coloplast Corp | $125.97 | 2022 | |
| Allergan, INC. | $121.01 | 2019-2022 | |
| Organon LLC | $19.85 | 2024-2025 | Jada System |
| Bayer Healthcare Pharmaceuticals INC. | $19.50 | 2019 | |
| Therapeuticsmd, INC. | $16.56 | 2019 | |
| Caldera Medical, INC | $15.98 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Segil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.